We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
-0.96%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$8.87B
AUM Growth
+$371M
Cap. Flow
+$510M
Cap. Flow %
5.75%
Top 10 Hldgs %
20.44%
Holding
2,307
New
202
Increased
1,106
Reduced
768
Closed
169

Sector Composition

Rank Sector Weight
1 Technology 5.47%
2 Financials 4.99%
3 Healthcare 3.94%
4 Industrials 3.75%
5 Consumer Discretionary 3.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VVR icon
2076
Invesco Senior Income Trust
VVR
$460M
$70K ﹤0.01%
16,021
-7,743
-33% -$34.2K
APYX icon
2077
Apyx Medical
APYX
$127M
$69K ﹤0.01%
+23,395
New +$60.2K
OXSQ icon
2078
Oxford Square Capital
OXSQ
$151M
$69K ﹤0.01%
11,248
CPIX icon
2079
Cumberland Pharmaceuticals
CPIX
$119M
$67K ﹤0.01%
10,000
AXAS
2080
DELISTED
Abraxas Petroleum Corp
AXAS
$66K ﹤0.01%
1,491
-134
-8% -$6.25K
SDRL
2081
DELISTED
Seadrill Limited Common Stock
SDRL
$65K ﹤0.01%
1,253
-110
-8% -$7.61K
XXII
2082
22nd Century Group
XXII
$1.52M
0
AUY
2083
DELISTED
Yamana Gold, Inc.
AUY
$63K ﹤0.01%
22,990
-2,837
-11% -$8.76K
ENDP
2084
DELISTED
Endo International plc
ENDP
$61K ﹤0.01%
+10,287
New +$71.9K
SGMA
2085
DELISTED
Sigmatron International
SGMA
$60K ﹤0.01%
10,400
-2,243
-18% -$17.7K
STNG icon
2086
Scorpio Tankers
STNG
$3.72B
$60K ﹤0.01%
3,069
-600
-16% -$15.2K
FCSC
2087
DELISTED
Fibrocell Science Inc.
FCSC
$58K ﹤0.01%
19,563
+945
+5% +$3.1K
SN
2088
DELISTED
Sanchez Energy Corporation
SN
$58K ﹤0.01%
18,550
+1,500
+9% +$6.21K
DALN
2089
DELISTED
DallasNews
DALN
$57K ﹤0.01%
2,775
-325
-10% -$6.56K
BTE icon
2090
Baytex Energy
BTE
$3.08B
$56K ﹤0.01%
20,273
+247
+1% +$718
INO icon
2091
Inovio Pharmaceuticals
INO
$79.1M
$56K ﹤0.01%
983
+58
+6% +$3.14K
AMRN
2092
Amarin Corp
AMRN
$296M
$54K ﹤0.01%
893
GPRO icon
2093
GoPro
GPRO
$107M
$54K ﹤0.01%
11,276
-6,445
-36% -$36.9K
OBE
2094
Obsidian Energy
OBE
$710M
$49K ﹤0.01%
7,174
-214
-3% -$1.56K
IEC
2095
DELISTED
IEC Electronics Corp.
IEC
$49K ﹤0.01%
10,853
-5,500
-34% -$22.7K
PER
2096
DELISTED
SANDRIDGE PERMIAN TRUST
PER
$47K ﹤0.01%
24,915
-3,420
-12% -$7.38K
CFBK icon
2097
CF Bankshares
CFBK
$231M
$46K ﹤0.01%
+3,636
New +$50K
HL icon
2098
Hecla Mining
HL
$11.9B
$45K ﹤0.01%
12,206
-601
-5% -$2.33K
MNKD icon
2099
MannKind Corp
MNKD
$1.23B
$44K ﹤0.01%
19,494
-2,826
-13% -$7.61K
VSLR
2100
DELISTED
VIVINT SOLAR, INC.
VSLR
$44K ﹤0.01%
+12,075
New +$41.7K

Similar funds

Cambridge Investment Research Advisors's Q1 2018 Portfolio in Review

As of Q1 2018, Cambridge Investment Research Advisors held 2,307 positions worth $8.87B, up 4.4% from $8.5B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Cambridge Investment Research Advisors deployed $510M of net new capital in Q1 2018, opening 202 new positions and adding to 1,106 existing holdings. Its largest new stake was BrightSpire Capital: 489,150 shares worth $9.27M.

By sector, the portfolio is most concentrated in Technology at 5.5% of assets, up from 5.3% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $24.6M trimmed.

  • Cambridge Investment Research Advisors's largest Q1 2018 buy was BrightSpire Capital: 489,150 shares worth $9.27M.
  • Cambridge Investment Research Advisors added most to iShares S&P Mid-Cap 400 Growth ETF in Q1 2018, an estimated $21.9M increase.
  • Cambridge Investment Research Advisors's biggest Q1 2018 reduction was iShares MSCI EAFE ETF, cutting an estimated $24.6M.
  • Cambridge Investment Research Advisors fully exited KB Financial Group in Q1 2018, selling an estimated $3.4M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 20% of its $8.87B portfolio in Q1 2018.
  • Cambridge Investment Research Advisors opened 202 new positions and closed 169 in Q1 2018.
  • Cambridge Investment Research Advisors's portfolio value rose 4.4% quarter-over-quarter to $8.87B.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2018, filed 9 May 2018.